| Code | 62362 | ||||||||||
| MA number | 15/0653/94-S | ||||||||||
| Product Form: | crm vag 1x40 g (tuba PE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Pfizer Europe MA EEIG, Belgium | ||||||||||
| Therapeutic Class: | 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | tube PE | ||||||||||
| Route of admin.: | Vaginal use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 23.09.1994 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_DALACIN V 2% crm vag_05.2021.pdf
|
| PIL: |
PIL_DALACIN V 2 % crm vag_05.2022.pdf
|
| Safety feature | Yes |
| Data update: | 06.04.2018 |
